Crossmark

A systematic review and meta-analysis comparing the cardiovascular effects of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 agonists in type 2 diabetes

Crossref DOI link: https://doi.org/10.1007/s40200-025-01741-2

Published Online: 2025-10-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Laibah Arshad

Sadia, Khudija https://orcid.org/0009-0002-1146-8568
Naveed, Rahma

Khalid, Rehan

Faisal, Rabail

Bilal, Abdur Rafay

Nawaz, Ayeza

Safdar, Abdullah

Siddique, Talha Saleh Bin

Ahmad, Saleh Saeed

Hussain, Muhammad Ubaid

Asghar, Muhammad Talha

Ahmad, Wajdan
License Information

Text and Data Mining valid from 2025-10-11

Version of Record valid from 2025-10-11
More Information

Article History

Received: 19 July 2025

Accepted: 6 September 2025

First Online: 11 October 2025

Declarations

:

: No Internal Review Board (IRB) permission is required for this review.

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below